Company: CGC
Filing Date: 2025-05-30
Form Type: POS AM
Source: 0001104659-25-054925
Chunk: 87

Company: Canopy Growth Corp
Filing Date: 2025-05-30
Form: POS AM
Chunk 87
---
2024 Warrant Shares. The January 2024 Units, including the Common Shares and January 2024 Warrants underlying the January 2024 Units, were issued by the Company in reliance on the exemption from securities registration in Section 4(a)(2) under the Securities Act.

#### Wana Shares
The Wana Shares were issued on April 30, 2024 pursuant to the terms of (i) the Initial Option Agreements and (ii) the Second A&R First Amendment. Pursuant to the terms of the Second A&R First Amendment, the Wana Grantors, each a Selling Securityholder, agreed to reduce the exercise price for the Wana Option and in exchange, among other things, we issued the Wana Shares to the Wana Grantors. Pursuant to the terms of the

<div align='center'>6</div>

TABLE OF CONTENTS

Initial Option Agreements, we agreed to register the resale of any Common Shares issued pursuant thereto, including the Wana Shares. The Wana Shares were issued by the Company in reliance on the exemption from securities registration in Section 4(a)(2) under the Securities Act.

#### May 2024 Issuance
In connection with the Company’s acquisition of The Supreme Cannabis Company, Inc. (“Supreme Cannabis”) in June 2021, the Company agreed to guarantee certain outstanding unsecured convertible debentures of Supreme Cannabis (the “Supreme Convertible Debentures”) and unsecured non-convertible debentures of Supreme Cannabis (the “Supreme Accretion Debentures” and, together with the Supreme Convertible Debentures, the “Supreme Debentures”).

On May 2, 2024, we entered into an exchange and subscription agreement (the “Exchange and Subscription Agreement”) with MMCAP International Inc. SPC (the “Investor”) pursuant to which, among other things, on May 14, 2024, the Investor delivered to the Company approximately C$27.5 million aggregate principal amount of outstanding Supreme Debentures maturing in September 2025 held by the Investor and paid the Company approximately US$50 million in exchange for the Company issuing to the Investor (i) the Convertible Debentures and (ii) the May 2024 Warrants. The Convertible Debentures bear interest at a rate of 7.50% per annum, payable in semi-annual payments in cash or, at the option of the Company, in Common Shares